Pallas Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Pallas Capital Advisors's DXCM Position: Q1 2026 in Review
Pallas Capital Advisors reduced its DexCom (DXCM) stake by 24% in Q1 2026, selling an estimated $117K and leaving 5,372 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #612.
Pallas Capital Advisors first reported a position in DXCM in Q1 2021 and has held it in 20 quarters since. The position peaked at $986K in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Pallas Capital Advisors held 5,372 shares of DexCom worth $337K as of Q1 2026.
- Pallas Capital Advisors sold 1,683 DexCom shares in Q1 2026, an estimated $117K.
- DexCom made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #612 holding.
- Pallas Capital Advisors first reported a position in DexCom in Q1 2021 and has held it in 20 quarters since.
- Pallas Capital Advisors's DexCom position peaked at $986K in Q3 2021.
- 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.